Gross profit increase of 32.6% and 11-point gross profit margin increase driven by higher-margin cartridge salesSubmitted FDA 510(k) and remain ...

Gross profit expected to surge by 32.6%Unaudited revenue of $0.61 million for fiscal Q2 and $1.48 million for the six months ended December 31, ...

In this post, I will focus on how companies around the world, and in different sectors, performed on their end game of ...

QIAGEN N.V.’s QGEN fourth-quarter 2024 adjusted earnings per share (EPS) were 61 cents, the same at the constant exchange ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.29. Operator: Thank you for standing by. My name ...

Perhaps the real advantage of AI in developing trading strategies, and then automating them, is that they enforce discipline ...

Q3 2025 Earnings Call Transcript February 11, 2025 Jerash Holdings (US), Inc. beats earnings expectations. Reported EPS is ...

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

Regenerative Medicine Market Growth BURLINGAME, CA, UNITED STATES, February 14, 2025 /EINPresswire / --The global Regenerative Medicin ...